Antioxidant vitamins and hyperbilirubinemia in neonates.
OBJECTIVE
Low antioxidant system may contribute to the severity of neonatal hyperbilirubinemia. The aim of this research was to explore the relationship between plasma vitamin E and C levels and the severity of hyperbilirubinemia in full-term neonates with normal glucose 6-phosphate dehydrogenase (G6PD) activities.


METHODS
A total of 130 full-term healthy live birth neonates of healthy mothers with normal G6PD activity were included in this study. In addition to routine blood analysis, plasma total bilirubin, vitamin E and C levels and G6PD activity were measured on the first day of life. None of the neonates was ABO incompatible or anemic.


RESULTS
Neonates who did not develop hyperbilirubinemia (n=119) had a mean plasma bilirubin level of 65+/-24 micromol/l (median 58.1), while neonates who developed significant hyperbilirubinemia (n=11) had a mean plasma bilirubin level of 238+/-56 micromol/l (median 246.2) on the first day of life. Mean plasma vitamin C levels of neonates who developed hyperbilirubinemia were significantly lower than those who did not develop hyperbilirubinemia (87+/-22 micromol/l (median 89.4) vs. 132+/-36 micromol/l (median 127.7), respectively, P=0.0001). Similar results were observed for plasma vitamin E levels in neonates who did or did not develop hyperbilirubinemia (7.5+/-2 micromol/l (median 6.3) vs. 10.4+/-5 micromol/l (median 9.1), respectively, P=0.001). Hemoglobin and hematocrit were significantly lower in neonates who developed hyperbilirubinemia (P=0.0002 and P=0.0003, respectively), although gestational age and birth weight for the two groups showed no significant difference.


CONCLUSIONS
The results of the present work indicate that low level of plasma vitamins C and E are associated with significant hyperbilirubinemia in full-term neonates.
Abdul-Razzak
Khalid K
KK
Department of Clinical Pharmacy, Jordan University of Science and Technology, Faculty of Pharmacy, Irbid, Jordan. kkalani@just.edu.jo
Nusier
Mohamad K
MK
Obediat
Ahmad D
AD
Salim
Ahmad M
AM
BMC Pediatr. 2004 Jul 20;4:14
15260886
Arch Dis Child Fetal Neonatal Ed. 1999 May;80(3):F235-7
10212090
Blood. 1967 Apr;29(4):481-93
6023063
Clin Chem. 1983 Apr;29(4):708-12
6831704
Clin Perinatol. 1990 Jun;17(2):371-9
2196135
J Biol Chem. 1996 May 3;271(18):10577-82
8631858
Arch Dis Child Fetal Neonatal Ed. 2003 Mar;88(2):F119-23
12598500
EXS. 1992;62:419-22
1450602
Proc Natl Acad Sci U S A. 1997 Oct 28;94(22):12128-32
9342374
Cell Biochem Funct. 2004 Sep-Oct;22(5):339-42
15338475
Am J Perinatol. 1998 Feb;15(2):133-40
9514139
Am Fam Physician. 2002 Feb 15;65(4):599-606
11871676
Biofactors. 1998;8(1-2):133-7
9699021
Minerva Pediatr. 2004 Aug;56(4):381-94
15457136
Biochem Pharmacol. 1991 Jul 25;42(4):883-8
1867643
Clin Chem. 1998 Dec;44(12):2551-3
9836729
N Engl J Med. 2006 May 4;354(18):1947-9
16672708
Pediatrics. 1998 Jun;101(6):995-8
9606225
Pediatrics. 2001 Jul;108(1):31-9
11433051
Blood. 1985 Dec;66(6):1272-7
4063520
Acta Paediatr Scand. 1988 May;77(3):349-56
3389126
Pediatr Res. 1999 Mar;45(3):355-62
10088654
Early Hum Dev. 2001 Nov;65 Suppl:S75-81
11755038
Pediatrics. 2000 Aug;106(2):E16
10920172
N Engl J Med. 2001 Feb 22;344(8):581-90
11207355
J Pediatr. 1967 Feb;70(2):166-71
5334979
J Pediatr. 1988 Jul;113(1 Pt 1):114-20
3385519
J Trop Pediatr. 1986 Oct;32(5):251-4
3795336
J Paediatr Child Health. 2004 Nov;40(11):633-7
15469533
Am J Clin Nutr. 1991 Jan;53(1 Suppl):201S-205S
1985388
Pediatrics. 1979 Sep;64(3):321-3
481976
J Pediatr. 1997 Jan;130(1):103-9
9003858
Ann Intern Med. 1987 Oct;107(4):526-45
3307585
Acta Paediatr Scand. 1976 May;65(3):361-7
1274569
JAMA. 1974 Dec 2;230(9):1304-5
4479604
Chang Gung Med J. 2005 Dec;28(12):846-51
16515018